What Is Lumiracoxib?

Mary McMahon
Mary McMahon

Lumiracoxib is a medication a doctor may prescribe for the treatment of pain and inflammation, if it is available in the nation where the doctor practices. This drug initially entered the market in 2006 and was subsequently withdrawn in a number of nations in 2007 in response to reports of serious adverse reactions. Some Latin American nations continue to allow the sale of lumiracoxib, and a doctor may choose to prescribe it in these regions.

Lumiracoxib is a pain reliever and fever reducer that is still in use in several Latin American countries.
Lumiracoxib is a pain reliever and fever reducer that is still in use in several Latin American countries.

Known by the brand name Prexige®, this drug is a prostaglandin inhibitor. It works by limiting the production of certain compounds associated with sending pain signals and triggering inflammation. It will also lower fevers. Doctors can recommend the drug for the treatment of acute pain and chronic inflammation in association with a variety of medical conditions. The dosage varies and typically starts low to limit the chance of adverse reactions.

Non-steroidal anti-inflammatory drugs like lumiracoxib are known for causing gastrointestinal side effects, but this drug tends to be less hard on the stomach because it doesn't eliminate compounds with a protective effect on the stomach and bowel lining. By leaving these chemicals intact, the drug is more likely to pass through the intestines without causing nausea, vomiting, and diarrhea. Some patients may still experience these side effects.

Fatigue and dizziness are also potential side effects, as are rare skin reactions. Some patients develop rashes, peeling, and blistering while taking the medication and should stop using it immediately if they develop these side effects. Lumiracoxib is also very hard on the liver and kidneys, as they must metabolize the drug and can become overwhelmed. The drug was withdrawn from the market in response to reports of serious liver impairment in patients on lumiracoxib.

If a doctor feels that this drug is appropriate for the patient, he will take a thorough history. He may also run some tests to check on liver and kidney function. The testing will determine whether the patient is a good candidate for lumiracoxib therapy. After prescribing the drug, the doctor typically asks the patient to submit to periodic examinations to check for dangerous side effects like liver damage. Patients who react badly will need to take a different medication to manage their conditions.

This oral medication should be stored in a cool, dry place, out of the reach of children and pets. Patients should not share it, because the dose is customized. Other people may experience adverse reactions to the drug if they have not been screened for safety first.

Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a wiseGEEK researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Readers Also Love

Discuss this Article

Post your comments
Forgot password?